• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-7e-5p 下调通过上调 M1 巨噬细胞中的 FasL 来调节免疫抑制性基质,从而促进低级别滤泡性淋巴瘤向侵袭性淋巴瘤的转化。

MiR-7e-5p downregulation promotes transformation of low-grade follicular lymphoma to aggressive lymphoma by modulating an immunosuppressive stroma through the upregulation of FasL in M1 macrophages.

机构信息

Department of Pathology, School of Biology & Basic Medical Sciences, Soochow University, Suzhou, 215123, China.

Department of Pathology, the First Affiliated Hospital of Soochow University, Suzhou, 215006, China.

出版信息

J Exp Clin Cancer Res. 2020 Nov 9;39(1):237. doi: 10.1186/s13046-020-01747-z.

DOI:10.1186/s13046-020-01747-z
PMID:33168041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7654609/
Abstract

BACKGROUND

In follicular lymphoma (FL), histologic transformation to high-grade FL and diffuse large B-cell lymphoma (DLBCL) is a critical adverse step in disease progression. Activation of the oncogene c-MYC and tumor microenvironment remodeling account for FL progression. A panel of microRNA (miRNA) was downregulated in transformed FL (tFL).

METHODS

Differentially expressed miRNAs were systematically compared in 11 lymph nodes from patients at different stages of disease. Expression of miR-7e-5p was analyzed in 46 B-cell lymphomas, including 30 FL tissues and 16 DLBCL tissues. In FL cells, transcriptional regulation of the oncogene c-MYC on its target miR-7e-5p was revealed by Chromatin Immunoprecipitation (ChIP) assay. Exosome, carrying differentially expressed miR-7e-5p was isolated and visualized by transmission electron microscope and fluorescence tracing. The effect of miR-7e-5p on recipient macrophage was determined by target gene quantification, flow cytometry, and TUNEL method in a cocultured system with miR-7e-5p-mimics or inhibitors treatment. Expression of miR-7e-5p targets, macrophage proportions, and clinical parameters were included for correlation analysis.

RESULTS

We determined that downregulation of miR-7e-5p, driven by c-MYC overexpression, was associated with poorer prognosis in FL patients. The decreased expression of miR-7e-5p in lymphoma cells led to a reduced exosomal transfer to surrounding macrophages. As a result, the target gene of miR-7e-5p, Fas ligand (FasL), was upregulated and activated the caspase signaling, which led to the apoptosis of M1 macrophages in tumor stroma. Finally, in transformed FL tissues, overexpression of FasL and activation of caspase proteins was detected in tumor stromal macrophages. Downregulation of miR-7e-5p was associated with poorer clinical outcomes.

CONCLUSION

Downregulation of exosomal miR-7e-5p induces stromal M1 macrophage apoptosis, which leads to immunosurveillance and transformation of FL.

摘要

背景

滤泡性淋巴瘤(FL)向高级别 FL 和弥漫性大 B 细胞淋巴瘤(DLBCL)的组织学转化是疾病进展中的一个关键不良步骤。癌基因 c-MYC 的激活和肿瘤微环境重塑解释了 FL 的进展。一组 microRNA(miRNA)在转化滤泡性淋巴瘤(tFL)中下调。

方法

在疾病不同阶段的 11 个淋巴结中系统比较差异表达的 miRNA。分析了 46 例 B 细胞淋巴瘤中的 miR-7e-5p 的表达,包括 30 例 FL 组织和 16 例 DLBCL 组织。在 FL 细胞中,通过染色质免疫沉淀(ChIP)试验揭示了癌基因 c-MYC 对其靶 miR-7e-5p 的转录调控。通过透射电子显微镜和荧光追踪分离并可视化携带差异表达 miR-7e-5p 的外泌体。在带有 miR-7e-5p-mimics 或抑制剂处理的共培养系统中,通过靶基因定量、流式细胞术和 TUNEL 方法确定 miR-7e-5p 对受体巨噬细胞的影响。进行 miR-7e-5p 靶基因、巨噬细胞比例和临床参数的相关性分析。

结果

我们确定,由 c-MYC 过表达驱动的 miR-7e-5p 的下调与 FL 患者的预后较差有关。淋巴瘤细胞中 miR-7e-5p 的表达降低导致周围巨噬细胞的外泌体转移减少。结果,miR-7e-5p 的靶基因 Fas 配体(FasL)上调并激活 caspase 信号,导致肿瘤基质中的 M1 巨噬细胞凋亡。最后,在转化的 FL 组织中,肿瘤基质巨噬细胞中 FasL 过表达和 caspase 蛋白激活被检测到。miR-7e-5p 的下调与较差的临床结局相关。

结论

下调外泌体 miR-7e-5p 诱导肿瘤基质 M1 巨噬细胞凋亡,导致 FL 的免疫监视和转化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758c/7654609/fe27667c79fb/13046_2020_1747_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758c/7654609/10ea9a9b2297/13046_2020_1747_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758c/7654609/38439bc06136/13046_2020_1747_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758c/7654609/f6eb0a33ac5d/13046_2020_1747_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758c/7654609/d5eb5f499114/13046_2020_1747_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758c/7654609/5d6a4a31b5b3/13046_2020_1747_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758c/7654609/c406d0dc322c/13046_2020_1747_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758c/7654609/fe27667c79fb/13046_2020_1747_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758c/7654609/10ea9a9b2297/13046_2020_1747_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758c/7654609/38439bc06136/13046_2020_1747_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758c/7654609/f6eb0a33ac5d/13046_2020_1747_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758c/7654609/d5eb5f499114/13046_2020_1747_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758c/7654609/5d6a4a31b5b3/13046_2020_1747_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758c/7654609/c406d0dc322c/13046_2020_1747_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758c/7654609/fe27667c79fb/13046_2020_1747_Fig7_HTML.jpg

相似文献

1
MiR-7e-5p downregulation promotes transformation of low-grade follicular lymphoma to aggressive lymphoma by modulating an immunosuppressive stroma through the upregulation of FasL in M1 macrophages.miR-7e-5p 下调通过上调 M1 巨噬细胞中的 FasL 来调节免疫抑制性基质,从而促进低级别滤泡性淋巴瘤向侵袭性淋巴瘤的转化。
J Exp Clin Cancer Res. 2020 Nov 9;39(1):237. doi: 10.1186/s13046-020-01747-z.
2
miR-31 and miR-17-5p levels change during transformation of follicular lymphoma.在滤泡性淋巴瘤转化过程中,miR-31和miR-17-5p水平发生变化。
Hum Pathol. 2016 Apr;50:118-26. doi: 10.1016/j.humpath.2015.11.011. Epub 2015 Nov 30.
3
downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels.下调(downregulation)通过上调 FOXP1 水平促进滤泡性淋巴瘤的高级别转化。
Blood. 2018 Nov 29;132(22):2389-2400. doi: 10.1182/blood-2018-06-855502. Epub 2018 Sep 13.
4
Systematic review of the potential of MicroRNAs in the management of patients with follicular lymphoma.系统评价 MicroRNAs 在滤泡性淋巴瘤患者管理中的潜力。
Crit Rev Oncol Hematol. 2021 Mar;159:103247. doi: 10.1016/j.critrevonc.2021.103247. Epub 2021 Jan 27.
5
MicroRNA expression profiling of Chinese follicular lymphoma by microarray: A preliminary study.利用基因芯片对中国滤泡性淋巴瘤进行微小RNA表达谱分析:一项初步研究。
Int Immunopharmacol. 2016 Oct;39:41-47. doi: 10.1016/j.intimp.2016.07.006. Epub 2016 Jul 10.
6
[The Importance of MicroRNA Deregulation in the Molecular Pathogenesis and Histological Transformation of Follicular Lymphoma].[微小RNA失调在滤泡性淋巴瘤分子发病机制和组织学转化中的重要性]
Klin Onkol. 2017 Spring;30(Supplementum1):163-165.
7
Regulation of the MIR155 host gene in physiological and pathological processes.miR-155 宿主基因在生理和病理过程中的调控。
Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14.
8
Cancer-derived exosomal miR-138-5p modulates polarization of tumor-associated macrophages through inhibition of KDM6B.肿瘤来源的外泌体 miR-138-5p 通过抑制 KDM6B 来调节肿瘤相关巨噬细胞的极化。
Theranostics. 2021 May 3;11(14):6847-6859. doi: 10.7150/thno.51864. eCollection 2021.
9
MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas.微小RNA特征可区分弥漫性大B细胞淋巴瘤和滤泡性淋巴瘤。
Br J Haematol. 2008 Sep;142(5):732-44. doi: 10.1111/j.1365-2141.2008.07237.x. Epub 2008 Jun 3.
10
Utility of immunohistochemistry with an antibody against MYC at the initial diagnosis of follicular lymphoma, grade 3A, for predicting a more aggressive clinical course: a case report and review of the literature.抗MYC抗体免疫组化在滤泡性淋巴瘤3A级初诊时预测更具侵袭性临床病程的效用:一例病例报告及文献复习
Int J Clin Exp Pathol. 2015 Jun 1;8(6):7559-64. eCollection 2015.

引用本文的文献

1
Critical Role of Extracellular Vesicles in Diffuse Large B-Cell Lymphoma; Pathogenesis, Potential Biomarkers, and Targeted Therapy-A Narrative Review.细胞外囊泡在弥漫性大B细胞淋巴瘤中的关键作用;发病机制、潜在生物标志物及靶向治疗——一篇叙述性综述
Biomedicines. 2024 Dec 12;12(12):2822. doi: 10.3390/biomedicines12122822.
2
Molecular Biomarkers in Prediction of High-Grade Transformation and Outcome in Patients with Follicular Lymphoma: A Comprehensive Systemic Review.分子生物标志物在预测滤泡性淋巴瘤患者高级别转化和结局中的作用:一项全面的系统性综述。
Int J Mol Sci. 2024 Oct 17;25(20):11179. doi: 10.3390/ijms252011179.
3
Gene targeted and immune therapies for nodal and gastrointestinal follicular lymphomas.

本文引用的文献

1
The presence of tumour-infiltrating lymphocytes (TILs) and the ratios between different subsets serve as prognostic factors in advanced hypopharyngeal squamous cell carcinoma.肿瘤浸润淋巴细胞(TILs)的存在及其不同亚群之间的比例可作为晚期下咽鳞状细胞癌的预后因素。
BMC Cancer. 2020 Aug 5;20(1):731. doi: 10.1186/s12885-020-07234-0.
2
Immunological Effects of Epigenetic Modifiers.表观遗传修饰剂的免疫效应
Cancers (Basel). 2019 Dec 1;11(12):1911. doi: 10.3390/cancers11121911.
3
JASPAR 2020: update of the open-access database of transcription factor binding profiles.
针对结内和胃肠道滤泡性淋巴瘤的基因靶向和免疫治疗。
World J Gastroenterol. 2023 Dec 28;29(48):6179-6197. doi: 10.3748/wjg.v29.i48.6179.
4
Tumor Cell-derived Extracellular Vesicles in Modulating Phenotypes and Immune Functions of Macrophages: Mechanisms and Therapeutic Applications.肿瘤细胞衍生的细胞外囊泡对巨噬细胞表型和免疫功能的调节作用:机制与治疗应用
J Cancer. 2023 May 8;14(8):1321-1334. doi: 10.7150/jca.84632. eCollection 2023.
5
Advances in the multi-omics landscape of follicular lymphoma.滤泡性淋巴瘤的多组学全景进展。
Int J Biol Sci. 2023 Mar 27;19(6):1955-1967. doi: 10.7150/ijbs.80401. eCollection 2023.
6
Exosomes and cancer immunotherapy: A review of recent cancer research.外泌体与癌症免疫疗法:近期癌症研究综述
Front Oncol. 2023 Jan 16;12:1118101. doi: 10.3389/fonc.2022.1118101. eCollection 2022.
7
Role of MicroRNA-7 (MiR-7) in Cancer Physiopathology.微小 RNA-7(MiR-7)在癌症病理生理学中的作用。
Int J Mol Sci. 2022 Aug 13;23(16):9091. doi: 10.3390/ijms23169091.
8
PHOSPHO1 Serves as a Key Metabolism-Related Biomarker in the Tumorigenesis of Diffuse Large B-cell Lymphoma.PHOSPHO1 作为弥漫性大 B 细胞淋巴瘤发生中关键的代谢相关生物标志物。
Curr Med Sci. 2022 Aug;42(4):754-768. doi: 10.1007/s11596-022-2612-6. Epub 2022 Aug 9.
9
Research progress on epigenetics of small B-cell lymphoma.小 B 细胞淋巴瘤表观遗传学研究进展。
Clin Transl Oncol. 2022 Aug;24(8):1501-1514. doi: 10.1007/s12094-022-02820-z. Epub 2022 Mar 25.
10
Exosomal non-coding RNAs: Emerging roles in bilateral communication between cancer cells and macrophages.外泌体非编码 RNA:癌细胞和巨噬细胞之间双向通讯的新兴作用。
Mol Ther. 2022 Mar 2;30(3):1036-1053. doi: 10.1016/j.ymthe.2021.12.002. Epub 2021 Dec 2.
JASPAR 2020:转录因子结合谱开放获取数据库的更新。
Nucleic Acids Res. 2020 Jan 8;48(D1):D87-D92. doi: 10.1093/nar/gkz1001.
4
Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration.在 24 个月内滤泡性淋巴瘤的疾病进展与肿瘤内免疫浸润减少有关。
J Clin Oncol. 2019 Dec 1;37(34):3300-3309. doi: 10.1200/JCO.18.02365. Epub 2019 Aug 28.
5
PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools.PANTHER 版本 14:更多基因组、一个新的 PANTHER GO-slim 和富集分析工具的改进。
Nucleic Acids Res. 2019 Jan 8;47(D1):D419-D426. doi: 10.1093/nar/gky1038.
6
downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels.下调(downregulation)通过上调 FOXP1 水平促进滤泡性淋巴瘤的高级别转化。
Blood. 2018 Nov 29;132(22):2389-2400. doi: 10.1182/blood-2018-06-855502. Epub 2018 Sep 13.
7
Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy.淋巴瘤免疫逃逸的两种策略:隐藏或防御——对免疫治疗的潜在影响。
Haematologica. 2018 Aug;103(8):1256-1268. doi: 10.3324/haematol.2017.184192. Epub 2018 Jul 13.
8
Activated CD8 T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells.激活的 CD8 T 细胞细胞外囊泡通过靶向病变间充质细胞来阻止肿瘤进展。
Nat Commun. 2018 Jan 30;9(1):435. doi: 10.1038/s41467-018-02865-1.
9
Cytoplasmic localization of the cell polarity factor scribble supports liver tumor formation and tumor cell invasiveness.细胞质定位的细胞极性因子 scribble 支持肝癌形成和肿瘤细胞侵袭。
Hepatology. 2018 May;67(5):1842-1856. doi: 10.1002/hep.29669. Epub 2018 Apr 1.
10
miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions.miRTarBase 更新 2018:一个经过实验验证的 microRNA-靶标相互作用的资源库。
Nucleic Acids Res. 2018 Jan 4;46(D1):D296-D302. doi: 10.1093/nar/gkx1067.